» Articles » PMID: 34692589

Changing Trends in Robot-assisted Radical Prostatectomy: Inverse Stage Migration-A Retrospective Analysis

Overview
Journal Prostate Int
Date 2021 Oct 25
PMID 34692589
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: With increasing availability of data on outcomes of surgery for prostate cancer, the profile of patients undergoing robot-assisted radical prostatectomy (RARP) has changed over the past decade. This impacts the decision-making process for surgeons and patients, particularly in low-incidence regions of Asia. Our institution was among the first in Asia to acquire a Vinci surgical robot in 2005. We evaluated the changes in the clinical and pathology profile of patients undergoing RARP at our institution over the past 15 years (2005-2019).

Methods: A retrospective analysis of patients undergoing RARP between April 2005 and December 2019 was conducted from the hospital database. The patients were divided into two groups; patients undergoing RARP from April 2005 to December 2012 (Group I, first 8 years) and January 2013 to December 2019 (Group II, next 7 years). The perioperative characteristics were compared between these two groups to assess changes in their profile and outcome.

Results: Four hundred forty-seven patients were included in this study; 244 (54.6%) in Group I and 203 (45.4%) in Group II. The median prostate specific antigen in Group II was significantly higher than that in Group I (14.5 vs. 11.7 ng/ml, = 0.016). Unfavorable pathological characteristics, i.e., Gleason Grade ≥3, perineural invasion, and the margin positivity rate increased substantially from 18.5% to 37.5%, 20.5% to 36.9%, and 15.2% to 26.6%, respectively, in Group II compared with Group I. More patients in Group II received adjuvant therapy than in Group I ( < 0.001).

Conclusion: There has been a change in profile of patients undergoing RARP and patients with more unfavorable disease characteristics such as higher prostate specific antigen and tumor grade are undergoing surgery. In line with international trends, the number of patients with low-grade disease undergoing surgery has substantially decreased. Multimodal treatment with adjuvant therapy is increasingly used, particularly in high-risk disease.

Citing Articles

Quadrifecta outcomes and their predictors following robotic radical prostatectomy: a study of newly established robotic center in India.

Aggarwal A, Singh M, Choudhary G, Singh V, Sandhu A, Bhirud D J Robot Surg. 2023; 17(5):2271-2277.

PMID: 37310526 DOI: 10.1007/s11701-023-01622-x.


Urinary tract infection after radiation therapy or radical prostatectomy on the prognosis of patients with prostate cancer: a population-based study.

Hyun J, Ha M, Oh S, Tae J, Chi B, Chang I BMC Cancer. 2023; 23(1):395.

PMID: 37138203 PMC: 10157974. DOI: 10.1186/s12885-023-10869-4.


Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study.

Park D, Kang H, Kwon S, Seo Y, Lee K, Hoon Kim B Prostate Int. 2023; 11(1):34-39.

PMID: 36910903 PMC: 9995689. DOI: 10.1016/j.prnil.2022.08.003.

References
1.
Iadeluca L, Mardekian J, Chander P, Hopps M, Makinson G . The burden of selected cancers in the US: health behaviors and health care resource utilization. Cancer Manag Res. 2017; 9:721-730. PMC: 5713681. DOI: 10.2147/CMAR.S143148. View

2.
Qi R, Moul J . High-Risk Prostate Cancer: Role of Radical Prostatectomy and Radiation Therapy. Oncol Res Treat. 2015; 38(12):639-44. DOI: 10.1159/000441736. View

3.
Schroder F, Hugosson J, Roobol M, Tammela T, Zappa M, Nelen V . Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014; 384(9959):2027-35. PMC: 4427906. DOI: 10.1016/S0140-6736(14)60525-0. View

4.
Tsang C, Lai T, Lam W, Ho B, Ng A, Ma W . Is prostate specific antigen (PSA) density necessary in selecting prostate cancer patients for active surveillance and what should be the cutoff in the Asian population?. Prostate Int. 2019; 7(2):73-77. PMC: 6664316. DOI: 10.1016/j.prnil.2018.03.002. View

5.
McClintock T, Wang Y, Cole A, Chung B, Kibel A, Chang S . Contemporary trends in the utilisation of radical prostatectomy. BJU Int. 2018; 122(5):726-728. DOI: 10.1111/bju.14411. View